Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Jan 28, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Brian McNamee, a member of the board of directors at Gen-Probe, does not plan to stand for re-election to the position. Gen-Probe said in a filing with the US Securities and Exchange Commission that McNamee, who has served on its board on and off since 2002, decided to depart the board due to the demands of his position as CEO of CSL.

Oxford Medical Diagnostics has appointed Graham Richards to serve on its science advisory board. Graham is a professor at Oxford University, where he spent a decade as chairman of the Department of Chemistry, and currently is head of the Centre for Computational Drug Discovery. He also was a founder of the Oxford University spinoff Oxford Molecular Group and a director of Isis Innovation.

Former US Food and Drug Administration Commissioner and Director of the National Cancer Institute Andrew von Eschenbach has joined the board of directors at Viamet Pharmaceuticals. The RTP, NC-based drug company develops metalloenzymes for use in potential therapeutics.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.